Total medical devices industry venture financing deals worth $1.1bn were announced in the US in July 2022, led by $225m venture financing of Delfi Diagnostics, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 39.9% over the previous month of $793.73m and a drop of 18.4% when compared with the last 12-month average of $1.36bn.
The US held a 67.68% share of the global medical devices industry venture financing deal value that totalled $1.64bn in July 2022.
In terms of venture financing deal activity, the US recorded 50 deals during July 2022, marking a decrease of 19.35% over the previous month and a drop of 35.90% over the 12-month average.
US medical devices industry venture financing deals in July 2022: Top deals
The top five medical devices industry venture financing deals accounted for 62.3% of the overall value during July 2022.
The combined value of the top five medical devices venture financing deals stood at $688m, against the overall value of $1.1bn recorded for the month.
The top five medical devices industry venture financing deals of July 2022 tracked by GlobalData were:
1) AV8 Ventures, Brown Advisory ,Cowen Healthcare Investments, DFJ Growth Management, Eli Lilly and Co, Foresite Capital Management, Illumina Ventures, Initiate Ventures, Menlo Ventures, Northpond Ventures, Open Field Capital, Orbimed Advisors, Osage University Partners, Point Field Partners,Point72 Ventures, PTX Capital, Rock Springs Capital Management, Samsara BioCapital, T Rowe Price Associates and Windham Venture Partners $225m venture financing deal with Delfi Diagnostics
2) The $223m venture financing of Cleerly by Breyer Capital, Cigna Ventures, DigiTx Partners, Fidelity Management & Research, Heartland Healthcare Capital, LRVHealth, Mirae Asset Capital, New Leaf Ventures, Novartis, Peter Thiel, Piper Sandler Merchant Banking, Sands Capital Management, T Rowe Price Associates,T. Rowe Price Investment Management and Vensana Capital
3) Medtronic, Perceptive Advisors, RTW Investments, SternAegis Ventures and Terumo $110m venture financing deal with Orchestra BioMed
4) The $75m venture financing of Medical Microinstruments by Andera Partners, BioStar Capital, Deerfield Management Co, Fountain Healthcare Partners, Panakes Partners, RA Capital Management and Samba Tech
5) ARTIS Ventures, Axial VC, DeciBio Consulting, KKRInc, Lansdowne Partners, OMX Ventures and SALT Fund $55m venture financing deal with Replay Therapeutics
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.